[Bleomycin, a new antibiotic possessing antitumor properties].
D000694:Anal Gland Neoplasms / Q000188:drug therapy; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D001831:Body Temperature / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000187:drug effects; D005260:Female; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D010412:Penile Neoplasms / Q000188:drug therapy; D012867:Skin / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy; D013302:Streptomyces; D013329:Structure-Activity Relationship; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
Bleomitsin, novyi antibiotik, obladaiushchii protivoopukholevymi svoistvami.